MONDAY, Oct. 28, 2024 -- The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients taking semaglutide...

FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...

FRIDAY, Nov. 1, 2024 -- The GLP-1 drug semaglutide can help obese people manage debilitating knee arthritis, a new trial has found. People who...

Obesity affects about 1 in 5 kids in the U.S. It’s a growing concern. Carrying extra weight can raise a child’s risk of future health problems....

THURSDAY, Nov. 7, 2024 -- The head of the company that makes the diabetes and obesity drugs Ozempic and Wegovy has warned that compounded versions of...

Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2 diabetes and congestive...

Liver cancer is the sixth leading cause of cancer death in the U.S. The most common type of liver cancer in adults is hepatocellular carcinoma (HCC),...

Scientists from Kobe University have found that stroke survivors who are slightly overweight tend to have fewer disabilities after their recovery....

A study published in Clinical Cancer Research confirmed that tissue stiffening in the most common types of breast cancer, HER2-negative, can...

FRIDAY, Nov. 1, 2024 -- Cirrhosis, hepatitis infection and other causes can trigger liver fibrosis -- a potentially lethal stiffening of tissue that,...